Compound Libraries

- A unique collection of 1793 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS); - Bioactivity and safety confirmed by pre-clinical research and clinical trials and most of them are approved by FDA, EMA, or NMPA; - Covers various major targets including membrane transporter, ion channel, etc.; Effect tool for research in cardiovascular disease. - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality;

- A unique collection of 262 toxic substances for high throughput screening (HTS) and high content screening (HCS); - Covers more than 150 targets related to immune diseases, neurological diseases, respiratory disorders, endocrine diseases, and cardiovascular diseases. - Includes 222 drugs with certain studies on mechanisms of toxicity; - Includes 89 natural products, most of which are effective ingredients of Chinese medicine and attractive for toxicological study. - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality;

- A unique collection of 1001 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening； - Include anti-cancer drugs, antibiotics, antituberculotic agents, antiretrovirals, antiepileptic agents, and cardiac medications, etc.； - Diversified in toxicities: Steatosis, Mitochondrial toxicity, cholestasis, drug allergy (hypersensitivity), etc.; - NMR and HPLC validated to ensure high purity and quality.

- Diversity: Selected from 1,600,000 drug-like compounds covering rich chemical scaffolds, 5000 compounds representing 5000 scaffolds； - Drug-likeness: filtering out reactive, toxic and otherwise undesirable structural motifs, and removing compounds that demonstrate a broad promiscuous activity (PAINS); - Strict quality control: more than 90% purity for each member with HNMR/LCMS validation； - Cost effective: Liquid small package is available.

- Diversity: Selected from 1,600,000 drug-like compounds, 10000 compounds representing 5000 scaffolds selected from a large drug-like chemical source； - Drug-likeness: filtering out reactive, toxic and otherwise undesirable structural motifs, and removing compounds that demonstrate a broad promiscuous activity (PAINS); - Strict quality control: more than 90% purity for each member with HNMR/LCMS validation； - Cost effective: Liquid small package is available. (Can be purchased together with Mini scaffolds library，forming a diversity library with more broad coverage.)

- A unique collection of 246 fragment-like small molecules for FBDD; - NMR and HPLC/LCMS validated to ensure high purity and quality;

- A unique collection of 197 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS); - Structurally diverse, medicinally active, and cell permeable; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - NMR and HPLC/LCMS validated to ensure high purity and quality;

- A unique collection of 660 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS); - Targets include Kinases, GPCR, and ion channels, etc.; - Effective tool for drug screening in brain disorders, such as brain tumor, mental disorders, and neurodegenerative diseases, etc.; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable and CNS penetrant; - NMR and HPLC/LCMS validated to ensure high purity and quality;

- A unique collection of 4533 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screening (HTS) and high content screening (HCS); - Documentation with clear source: isolated natural products from plant, animal, microorganism, etc. - Structurally diverse: 4533 natural products, including diverse types of structures, such as alkaloids, limonoids, sequiterpenes, diterpenes, pentacyclic triterpenes, sterols, and many other representatives which provide the structural diversity inherent in this group; - Detailed compound information with structure, solubility, target, activity, IC50 value, and biological activity description; - Cost-effective and competitive price to save your fundings.